硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 BTN3A2 抗体对
试剂盒

抗人 BTN3A2 抗体对

01AB02964

Butyrophilin subfamily 3 member A2 (BTN3A2) is a type I transmembrane protein encoded by the BTN3A2 gene located on chromosome 6. It plays a significant role in the immune system, particularly in the activation of Vγ9Vδ2 T cells, which are crucial for immune responses against infections and tumors. BTN3A2 lacks the B30.2 domain found in other butyrophilins but contains one V-type immunoglobulin-like domain, contributing to its function in immune modulation. Elevated expression of BTN3A2 has been associated with various diseases, including Systemic Lupus Erythematosus and ovarian cancer, where it may enhance immune co-stimulation and influence T-cell proliferation and cytokine production. The protein's structure allows it to interact with specific antibodies, further elucidating its role in immune signaling pathways.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
BTN3A2
基因别名
BT3.2; BTF3; BTF4
蛋白别名
butyrophilin subfamily 3 member A2; BTN3A2
UniProt
P78410
物种
Human

产品详情

靶点名称
BTN3A2
蛋白名称
butyrophilin subfamily 3 member A2
蛋白别名
Butyrophilin subfamily 3 member A2
靶点基因名
BTN3A2
基因别名
BT3.2; BTF3; BTF4
UniProt
P78410
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Butyrophilin subfamily 3 member A2 (BTN3A2) is a type I transmembrane protein encoded by the BTN3A2 gene located on chromosome 6. It plays a significant role in the immune system, particularly in the activation of Vγ9Vδ2 T cells, which are crucial for immune responses against infections and tumors. BTN3A2 lacks the B30.2 domain found in other butyrophilins but contains one V-type immunoglobulin-like domain, contributing to its function in immune modulation. Elevated expression of BTN3A2 has been associated with various diseases, including Systemic Lupus Erythematosus and ovarian cancer, where it may enhance immune co-stimulation and influence T-cell proliferation and cytokine production. The protein's structure allows it to interact with specific antibodies, further elucidating its role in immune signaling pathways.